Articles citing this paper

Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies

Disclosing the redox metabolism of drugs: The essential role of electrochemistry

Synthesis and unusual ring transformation of 1-acyl-3-(ferrocenylmethylidene)-piperazine-2,5-diones

Targeted and multifunctional arene ruthenium chemotherapeutics

Quantum Chemical and Molecular Docking Studies of [(η6-Cp*Rh-Tyr1)-Leu-enkephalin]2+ to G-Protein-Coupled μ-, ∂-, and κ-Opioid Receptors and Comparisons to the Neuropeptide [Tyr1]-Leu-enkephalin: Conformations, Noncovalent Amino Acid Binding Sites, Binding Energies, Electronic Factors, and Receptor Distortion Forces

Bioorganometallics: First examples of cyclometalated iridium(III) complexes containing di- and tripeptide ester ligands

Bioorganometallic Chemistry. 27. Synthetic, X-ray Crystallographic, and Competitive Binding Studies in the Reactions of Nucleobases, Nucleosides, and Nucleotides with [Cp*Rh(H2O)3](OTf)2, as a Function of pH, and the Utilization of Several Cp*Rh–DNA Base Complexes in Host–Guest Chemistry

A novel type of organometallic 2-R-2,4-dihydro-1H-3,1-benzoxazine with R = [M(η5-C5H4)(CO)3] (M = Re or Mn) units. Experimental and computational studies of the effect of substituent R on ring-chain tautomerism

In search of biocatalytic remedy for organotin compounds- the recalcitrant eco-toxicants

Neutral and cationic multinuclear half-sandwich rhodium and iridium complexes coordinated to poly(propyleneimine) dendritic scaffolds: Synthesis and cytotoxicity

Efficient photodynamic therapy of cancer using chemotherapeutic porphyrin–ruthenium metalla-cubes

Pd(II) complexes with N-substituted pyrazoles as ligands. The influence of the R group [OMe versus NMe2] of [1-{R–(CH2)2–}-3,5-Ph2–(C3HN2)] on their cytotoxic activity on breast cancer cell lines

The reactions of α-amino acids and α-amino acid esters with high valent transition metal halides: synthesis of coordination complexes, activation processes and stabilization of α-ammonium acylchloride cations

The Chemoselective Reactions of Tyrosine-Containing G-Protein-Coupled Receptor Peptides with [Cp*Rh(H2O)3](OTf)2, Including 2D NMR Structures and the Biological Consequences

An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway

La(OTf)3-mediated self-organization of guanosine with an alkynyl-Au(i)PPh3 moiety to induce Au(i)–Au(i) interactions

Approaches to the design of catalytic metallodrugs

Evaluation of the in vitro anticancer activity of cyclometalated half-sandwich rhodium and iridium complexes coordinated to naphthaldimine-based poly(propyleneimine) dendritic scaffolds

Contrasting Reactivity and Cancer Cell Cytotoxicity of Isoelectronic Organometallic Iridium(III) Complexes

Organometallic Iridium(III) Cyclopentadienyl Anticancer Complexes Containing C,N-Chelating Ligands

Heterodi‐ (Fe, Pd/Pt) and Heterotrimetallic (Fe2, Pd) Complexes Derived from 4‐(Ferrocenylmethyl)‐N‐(2‐methoxyethyl)‐3,5‐­diphenylpyrazole as Potential Antitumoral Agents

Improved Catalytic Activity of Ruthenium–Arene Complexes in the Reduction of NAD+

Organotin polymers as anticancer and antiviral agents

Design of Multifunctional IridiumIII Compounds as a Potential Therapeutic Agents from Basic Molecular Scaffolds

Organometallic Iridium Complexes with Glucose Based Phosphite Ligands

Organometallic Pyridylnaphthalimide Complexes as Protein Kinase Inhibitors

P-donor ligand containing ruthenium half-sandwich complexes as protein kinase inhibitors

Organometallic anticancer agents that interfere with cellular energy processes: a subtle approach to inducing cancer cell death

ChemInform Abstract: A Bioorganometallic Chemistry Overview: From Cytochrome P450 Enzyme Metabolism of Organotin Compounds to Organorhodium‐Hydroxytamoxifen Complexes with Potential Anticancer Properties; a 37 Year Perspective at the Interface of Organometallic Chemistry and Biology

Organometallic Ruthenium and Iridium Transfer‐Hydrogenation Catalysts Using Coenzyme NADH as a Cofactor

Nucleoside Analogues with a 1,3‐DieneFe(CO)3 Substructure: Stereoselective Synthesis, Configurational Assignment, and Apoptosis‐Inducing Activity

Organometallic Ruthenium and Iridium Transfer‐Hydrogenation Catalysts Using Coenzyme NADH as a Cofactor

Development of a novel low-flow ion source/sampling cone geometry for inductively coupled plasma mass spectrometry and application in hyphenated techniques